Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
Kinga KrzyżowskaAureliusz KolonkoPiotr GizaJerzy ChudekAndrzej WięcekPublished in: BioMed research international (2018)
Initial tacrolimus dose reduction should be considered in older, overweight, or obese kidney transplant recipients and in subjects with anti-HCV antibodies. Moreover, dose reduction of tacrolimus is especially important in patients with coexisting multiple risk factors.